Dr Kim Donoghue
Kim is a Trial Manager at the National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IOPPN). She completed her PhD at the University of Nottingham, which investigated the effect of substance misuse on cognitive function in those with a first episode of psychosis over time. Kim Joined the National Addiction Centre in 2012 coordinating a clinical trial that investigated the role of cortisol in memory and depression in alcohol dependence.
Kim’s main research interests include treatments for problem alcohol use and the impact of drug and alcohol use on cognitive function. Kim is a co-applicant and trial manager for the National Institute for Mental Health Research funded clinical trial, Alcohol Dependence and Adherence to Medicine (ADAM). This research is looking at how we can better support people taking medication for alcohol dependence. This research involves a collaboration between researchers, addiction treatment services nationally, pharmacists and the pharmaceutical industry. Kim has also received funding to investigate the rates and predictors of prescribing of medications for alcohol relapse prevention in England (Alcohol Research UK).
A full list of Kim's publications can be found on the King's Research Portal.
Kim is a member of the Addictions Department's Diversity & Inclusion Working Group.